Accuray (ARAY) Total Debt (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.84% |
| Dec 31, 2025 | -3.05% |
| Sep 30, 2025 | 2.67% |
| Jun 30, 2025 | -21.44% |
| Mar 31, 2025 | -0.99% |
| Dec 31, 2024 | 3.10% |
| Sep 30, 2024 | -1.11% |
| Jun 30, 2024 | -0.77% |
| Mar 31, 2024 | -0.72% |
| Dec 31, 2023 | -0.72% |
| Sep 30, 2023 | -0.71% |
| Jun 30, 2023 | -0.71% |
| Mar 31, 2023 | -0.70% |
| Dec 31, 2022 | 1.97% |
| Sep 30, 2022 | -2.30% |
| Jun 30, 2022 | -0.43% |
| Mar 31, 2022 | -0.43% |
| Dec 31, 2021 | -7.98% |
| Sep 30, 2021 | 13.82% |
| Jun 30, 2021 | -5.05% |
| Mar 31, 2021 | 1.34% |
| Dec 31, 2020 | 0.51% |
| Sep 30, 2020 | -5.08% |
| Jun 30, 2020 | -0.71% |
| Mar 31, 2020 | 3.70% |
| Dec 31, 2019 | -2.44% |
| Sep 30, 2019 | 17.90% |
| Jun 30, 2019 | 9.51% |
| Mar 31, 2019 | 6.68% |
| Dec 31, 2018 | 6.13% |
| Sep 30, 2018 | -1.64% |
| Jun 30, 2018 | -2.42% |
| Mar 31, 2018 | -20.93% |
| Dec 31, 2017 | 7.50% |
| Sep 30, 2017 | -3.98% |
| Jun 30, 2017 | -3.21% |
| Mar 31, 2017 | -0.08% |
| Dec 31, 2016 | -2.77% |
| Sep 30, 2016 | -16.82% |
| Jun 30, 2016 | 0.35% |
| Mar 31, 2016 | 1.43% |
| Dec 31, 2015 | 0.95% |
| Sep 30, 2015 | 2.56% |